세계의 셀 기반 어세이 및 하이 컨텐트 스크리닝 세계 시장 : 사용자별, 제품별 예측 - 주요 컨설턴트 가이드 포함(2025-2029년)

Cell Based Assay & High Content Screening Markets. Forecasts by User and Product. With Executive and Consultant Guides. 2025 to 2029

US $ 6,995 ￦ 9,876,000

PDF (Single User License)

PDF 보고서를 1명(One device)만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,495 ￦ 14,818,000

PDF (Five User License)

PDF 보고서를 동일 사업장의 5명(Five devices)까지 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 13,995 ￦ 19,760,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

셀 기반 어세이는 의약품 개발과 과학 연구의 기둥이며, 유행 후 현재 연구 활동이 회복되고 있습니다. 게다가, 새로운 기술은 셀 기반 어세이을 세포 기능의 모든 측면을 측정하는 데 사용할 수 있습니다. 이 시장은 머무르지 않고 계속 성장하고 있습니다. 제약 업계의 주요 제품은 생명 공학의 핵심 존재가되고 있습니다.

이 보고서는 세계 셀 기반 어세이 및 하이 컨텐트 스크리닝 시장을 조사했으며, 시장 개요와 함께 사용자별, 제품 별 동향 및 시장 진출 기업 프로파일을 제공합니다.

목차

제1장 시장 가이드

제2장 소개와 시장 정의

• 셀 기반 어세이란 무엇인가
• 임상시험 실패
• 감염이 보다 큰 역할을 한다
• 시장의 정의
• 조사 방법
• 미국의 의료 시장과 의약품 조사비- 전망

제3장 셀 기반 어세이-기술 가이드

• 세포 배양
• 세포 분석
• 세포 생존율 분석
• 세포 증식 분석
• 세포독성 검정
• 세포 노화 분석
• 아폽토시스
• 오토퍼지
• 괴사
• 산화 스트레스
• 2D vs 3D
• 시그널 전달 경로, GPCR
• 면역조절과 억제
• 리포터 유전자 기술
• CBA 설계·개발
• 셀 기반 어세이 - 요점

제4장 업계 개요

• 시장 진입기관
  • 학술연구기관
  • CRO
  • 유전체 장비 공급업체
  • 세포 분리 및 관찰 공급자
  • 세포주 및 시약 공급업체
  • 제약회사
  • 감사기관
  • 인증기관

제5장 시장 동향

• 성장 촉진요인
• 성장 억제요인
• 기술 개발

제6장 셀 기반 어세이의 최근 동향

제7장 주요 기업 프로파일

• Abcam
• Agilent
• Aurora Biomed
• Axxam
• Beckman Coulter Diagnostics
• Becton, Dickinson and Company
• Berkley Lights
• BioIVT
• Bio-Rad Laboratories, Inc.
• BMG Labtech
• Bruker
• Cell Biolabs, Inc.
• Cell Signaling Technology, Inc.
• Charles River Laboratories
• Corning, Inc.
• Cytek Biosciences
• Cytovale
• Deepcell
• Enzo Biochem
• Eurofins DiscoverX Corporation
• Evotec AG
• Excellerate Bioscience
• Fujifilm Cellular Dynamics International
• Genedata
• Hemogenix
• Invivogen
• Leica Biosystems
• Lonza Group Ltd.
• Luminex Corp(DiaSorin)
• Merck & Co., Inc
• Miltenyi Biotec
• Molecular Devices
• Nanion
• Ncardia
• New England Biolabs, Inc.
• Novogene Bioinformatics Technology Co., Ltd.
• Olympus
• Origene Technologies
• Promega
• Qiagen
• Reaction Biology
• Recursion Pharma
• Revvity
• Roche Diagnostics
• Sartorius
• Sartorius-ForteBio
• Sartorius-IntelliCyt
• Singleron Biotechnologies
• Sony Biotechnology
• SPT Labtech
• Stemcells Technologies Canada Inc.
• Tecan
• Thermo Fisher Scientific Inc.
• Vitro Biopharma

제8장 세계 시장 규모

• 세계 시장 개요, 국가별
• 세계 시장 개요, 사용자별
• 세계 시장 개요, 제품별

제9장 세계 시장, 사용자별

• 제약회사
• 연구기관
• 산업/화장품

제10장 셀 기반 어세이, 제품별

• 기기
• 시약
• 서비스
• 소프트웨어

제11장 부록

JHS

영문 목차

영문목차

Report Overview:

Cell Based Assays are a mainstay of drug development and scientific research, and now, post pandemic, research activity is rebounding. On top of this new technology is allowing Cell Based Assays to be used to measure any aspect of cell function. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

Table of Contents

1. Market Guides

• 1.1. Situation Analysis
• 1.2. Guide for Executives and Marketing Staff
• 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

• 2.1. What are Cell Based Assays?
• 2.2. Clinical Trial Failures
  • 2.2.1. Immuno-oncology Plays a Leading Role in Cell Based Assays
• 2.3. Infectious Disease Will Play a Larger Role
• 2.4. Market Definition
  • 2.4.1. Market Size
  • 2.4.2. Currency
  • 2.4.3. Years
• 2.5. Methodology
  • 2.5.1. Methodology
  • 2.5.2. Sources
  • 2.5.3. Authors
• 2.6. U.S. Medical Market and Pharmceutical Research Spending - Perspective
  • 1.5.1. U.S. Expenditures for Pharmaceutical Research

3. Cell Based Assays - Guide to Technology

• 3.1. Cell Cultures
  • 3.1.1. Cell Lines
  • 3.1.2. Primary Cells
  • 3.1.3. Stem Cells
  • 3.1.4. iPSC's - The Special Case
• 3.2. Cell Assays
• 3.3. Cell Viability Assays
• 3.4. Cell Proliferation Assays
• 3.5. Cytotoxicity Assays
• 3.6. Cell Senescence Assays
• 3.7. Apoptosis
• 3.8. Autophagy
• 3.9. Necrosis
• 3.10. Oxidative Stress
• 3.11. 2D vs. 3D
• 3.12. Signalling Pathways, GPCR
• 3.13. Immune Regulation & Inhibition
• 3.14. Reporter Gene Technology
• 3.15. CBA Design & Development
• 3.16. Cell Based Assays - The Takeaway

4. Industry Overview

• 4.1. Players in a Dynamic Market
  • 4.1.1. Academic Research Lab
  • 4.1.2. Contract Research Organization
  • 4.1.3. Genomic Instrumentation Supplier
  • 4.1.4. Cell Separation and Viewing Supplier
  • 4.1.5. Cell Line and Reagent Supplier
  • 4.1.6. Pharmaceutical Company
  • 4.1.7. Audit Body
  • 4.1.8. Certification Body

5. Market Trends

• 5.1. Factors Driving Growth
  • 5.1.1. Candidate Growth
  • 5.1.2. Immuno-oncology
  • 5.1.3. Genomic Blizzard
  • 5.1.4. Technology Convergence
  • 5.1.5. The Insurance Effect
• 5.2. Factors Limiting Growth
  • 5.2.1. CBA Development Challenges
  • 5.2.2. Instrument Integration
  • 5.2.3. Protocols
• 5.3. Technology Development
  • 5.3.1. 3D Assays
  • 5.3.2. Automation
  • 5.3.3. Software
  • 5.3.4. Primary Cells
  • 5.3.5. Signalling and Reporter Genes
  • 5.3.6. The Next Five Years

6. Cell Based Assays Recent Developments

• 6.1. Recent Developments
  • 6.1.1. Importance of These Developments
  • 6.1.2. How to Use This Section
• 6.2. New cell-based Screening Panel
• 6.3. New platform will accelerate single-cell analysis workflow
• 6.4. CytoTronics Announces Pixel Octo
• 6.5. Cell Painting boosts high-throughput screening
• 6.6. Castle Biosciences Sees Big Gains in New Testing Niches
• 6.7. Cell-Based Assay Outperforms Others
• 6.8. 3D spheroid model Monitors T-cell invasion
• 6.9. BioAuxilium Launches New Biomarker Assay
• 6.10. Charles River Laboratories Acquires SAMDI Tech
• 6.11. Axion BioSystems Launches New High-Throughput Live-Cell Imaging Platform
• 6.12. Fujifilm's Life Sciences Invests in PhenoVista Biosciences
• 6.13. Nucleai Launches New Multiplex Imaging Spatial Analysis Solution
• 6.14. BIO-TECHNE ANNOUNCES MULTI-OMIC RNASCOPE ASSAYS
• 6.15. Indivumed, CellPhenomics Partner on Cancer Drug Target Research
• 6.16. Synthego to Accelerate Drug Discovery
• 6.17. Long COVID Detected By Cell-Based Assay
• 6.18. Nanolive closes a USD 20 million Funding Round
• 6.19. Depixus Seeks to Commercialize 'Magnetic Tweezers' for Drug Discovery
• 6.20. BioAuxilium Research Expands its Cell Signaling Assay Portfolio
• 6.21. Droplet Genomics Debuts New Microfluidic Screening Platform
• 6.22. DLP Plus Single-Cell Sequencing Method Spreads From Canada to Cancer Labs Worldwide
• 6.23. Secondcell Bio to Make Creation of Cell Lines Easy
• 6.24. Nanolitre-scale cell assays developed with droplet microarraymass spec
• 6.25. Thermo Fisher Scientific Acquires Cell Sorting Technology
• 6.26. Cellink to Distribute Phasefocus High-Content Cell Imaging Platform
• 6.27. Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance
• 6.28. Cancer Genetics to Acquire Organoid Startup Stemonix
• 6.29. Curi Bio Acquires Artificial Intelligence Firm Dana Solutions
• 6.30. CRISPR Screens Uncover Novel Cancer Therapy Targets
• 6.31. ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam

7. Profiles of Key Cell Based Assay Companies

• 7.1. Abcam
• 7.2. Agilent
• 7.3. Aurora Biomed
• 7.4. Axxam
• 7.5. Beckman Coulter Diagnostics
• 7.6. Becton, Dickinson and Company
• 7.7. Berkley Lights
• 7.8. BioIVT
• 7.9. Bio-Rad Laboratories, Inc.
• 7.10. BMG Labtech
• 7.11. Bruker
• 7.12. Cell Biolabs, Inc.
• 7.13. Cell Signaling Technology, Inc.
• 7.14. Charles River Laboratories
• 7.15. Corning, Inc.
• 7.16. Cytek Biosciences
• 7.17. Cytovale
• 7.18. Deepcell
• 7.19. Enzo Biochem
• 7.20. Eurofins DiscoverX Corporation
• 7.21. Evotec AG
• 7.22. Excellerate Bioscience
• 7.23. Fujifilm Cellular Dynamics International
• 7.24. Genedata
• 7.25. Hemogenix
• 7.26. Invivogen
• 7.27. Leica Biosystems
• 7.28. Lonza Group Ltd.
• 7.29. Luminex Corp (DiaSorin)
• 7.30. Merck & Co., Inc
• 7.31. Miltenyi Biotec
• 7.32. Molecular Devices
• 7.33. Nanion
• 7.34. Ncardia
• 7.35. New England Biolabs, Inc.
• 7.36. Novogene Bioinformatics Technology Co., Ltd.
• 7.37. Olympus
• 7.38. Origene Technologies
• 7.39. Promega
• 7.40. Qiagen
• 7.41. Reaction Biology
• 7.42. Recursion Pharma
• 7.43. Revvity
• 7.44. Roche Diagnostics
• 7.45. Sartorius
• 7.46. Sartorius-ForteBio
• 7.47. Sartorius-IntelliCyt
• 7.48. Singleron Biotechnologies
• 7.49. Sony Biotechnology
• 7.50. SPT Labtech
• 7.51. Stemcells Technologies Canada Inc.
• 7.52. Tecan
• 7.53. Thermo Fisher Scientific Inc.
• 7.54. Vitro Biopharma

8. Global Market Size

• 8.1. Global Market Overview by Country
  • 8.1.1. Table - Global Market by Country
  • 8.1.2. Chart - Global Market by Country
• 8.2. Global Market by User - Overview
  • 8.2.1. Table - Global Market by User
  • 8.2.2. Chart - Global Market by User - Base/End Year Comparison
  • 8.2.3. Chart - Global Market by User - Base Year
  • 8.2.4. Chart - Global Market by User - End Year
  • 8.2.5. Chart - Global Market by User - Share by Year
• 8.3. Global Market by Product Class - Overview
  • 8.3.1. Table - Global Market by Product Class
  • 8.3.2. Chart - Global Market by Product Class - Base/End Year Comparison
  • 8.3.3. Chart - Global Market by Product Class - Base Year
  • 8.3.4. Chart - Global Market by Product Class - End Year
  • 8.3.5. Chart - Global Market by Product Class - Share by Year

9. Global Market by User Type

• 9.1. Pharma
  • 9.1.1. Table Pharma - by Country
  • 9.1.2. Chart - Pharma Growth
• 9.2. Research
  • 9.2.1. Table Research - by Country
  • 9.2.2. Chart - Research Growth
• 9.3. Industry/Cosmetic
  • 9.3.1. Table Industry/Cosmetic - by Country
  • 9.3.2. Chart - Industry/Cosmetic Growth

10. Cell Based Assay by Product Class

• 10.1. Instrument
  • 10.1.1. Table Instrument - by Country
  • 10.1.2. Chart - Instrument Growth
• 10.2. Reagent
  • 10.2.1. Table Reagent - by Country
  • 10.2.2. Chart - Reagent Growth
• 10.3. Services
  • 10.3.1. Table Services - by Country
  • 10.3.2. Chart - Services Growth
• 10.4. Software
  • 10.4.1. Table Software - by Country
  • 10.4.2. Chart - Software Growth

11. Appendices

• 11.1. FDA Cancer Drug Approvals by Year
• 11.2. Clinical Trials Started
• 11.3. Share of Pharma R&D by Country

관련자료